IHL
INDP icon

Investment House LLC’s Indaptus Therapeutics INDP Stock Holding History

Investment House LLC’s Portfolio INDP Stock Details INDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,602
Closed -$70.9K – 229
2025
Q1 		$70.9K Buy
4,602
+1,024
+29% +$23.6K ﹤0.01% 212
2024
Q4 		$84.4K Buy
3,578
+7
+0.2% +$222 ﹤0.01% 198
2024
Q3 		$124K Sell
3,571
-87
-2% -$4.27K 0.01% 205
2024
Q2 		$217K Hold
3,658
– – 0.01% 200
2024
Q1 		$229K Hold
3,658
– – 0.01% 204
2023
Q4 		$180K Sell
3,658
-15
-0.4% -$943 0.01% 189
2023
Q3 		$283K Sell
3,673
-194
-5% -$13.1K 0.02% 166
2023
Q2 		$207K Buy
3,867
+452
+13% +$26.4K 0.02% 181
2023
Q1 		$177K Hold
3,415
– – 0.01% 178
2022
Q4 		$139K Hold
3,415
– – 0.01% 167
2022
Q3 		$207K Hold
3,415
– – 0.02% 171
2022
Q2 		$250K Hold
3,415
– – 0.02% 158
2022
Q1 		$383K Hold
3,415
– – 0.03% 147
2021
Q4 		$545K Buy
3,415
+2,499
+273% +$464K 0.04% 136
2021
Q3 		$201K Buy
+916
New +$264K 0.01% 183

Other funds holding INDP

SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Investment House LLC's INDP Position: Q2 2025 in Review

Investment House LLC sold out of Indaptus Therapeutics (INDP) in Q2 2025, closing a stake of 4,602 shares — an estimated $70.9K sold.

Investment House LLC first reported a position in INDP in Q3 2021 and held it in 15 quarters. The position peaked at $545K in Q4 2021. 5 funds tracked by Wall St. Rank hold INDP as of Q2 2025.

  • Investment House LLC reported no remaining Indaptus Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Investment House LLC sold 4,602 Indaptus Therapeutics shares in Q2 2025, an estimated $70.9K.
  • Investment House LLC first reported a position in Indaptus Therapeutics in Q3 2021 and held it in 15 quarters.
  • Investment House LLC's Indaptus Therapeutics position peaked at $545K in Q4 2021.
  • 5 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q2 2025.

Based on Investment House LLC's 13F filing for Q2 2025, filed 14 Aug 2025.